2
|
Liu Z, Liu Z, Zhou X, Lu Y, Yao Y, Wang W, Lu S, Wang B, Li F, Fu W. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Hum Genomics 2022; 16:5. [PMID: 35109912 PMCID: PMC8812245 DOI: 10.1186/s40246-022-00377-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Accepted: 12/03/2021] [Indexed: 12/12/2022] Open
Abstract
Background Aerobic glycolysis is an emerging hallmark of cancer. Although some studies have constructed glycolysis-related prognostic models of colon adenocarcinoma (COAD) based on The Cancer Genome Atlas (TCGA) database, whether the COAD glycolysis-related prognostic model is appropriate for distinguishing the prognosis of rectal adenocarcinoma (READ) patients remains unknown. Exploring critical and specific glycolytic genes related to READ prognosis may help us discover new potential therapeutic targets for READ patients. Results Three gene sets, HALLMARK_GLYCOLYSIS, REACTOME_GLYCOLYSIS and REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM, were both significantly enriched in both COAD and READ through glycolysis-related gene set enrichment analysis (GSEA). We found that six genes (ANKZF1, STC2, SUCLG2P2, P4HA1, GPC1 and PCK1) were independent prognostic genes in COAD, while TSTA3 and PKP2 were independent prognostic genes in READ. Glycolysis-related prognostic model of COAD and READ was, respectively, constructed and assessed in COAD and READ. We found that the glycolysis-related prognostic model of COAD was not appropriate for READ, while glycolysis-related prognostic model of READ was more appropriate for READ than for COAD. PCA and t-SNE analysis confirmed that READ patients in two groups (high and low risk score groups) were distributed in discrete directions based on the glycolysis-related prognostic model of READ. We found that this model was an independent prognostic indicator through multivariate Cox analysis, and it still showed robust effectiveness in different age, gender, M stage, and TNM stage. A nomogram combining the risk model of READ with clinicopathological characteristics was established to provide oncologists with a practical tool to evaluate the rectal cancer outcomes. GO enrichment and KEGG analyses confirmed that differentially expressed genes (DEGs) were enriched in several glycolysis-related molecular functions or pathways based on glycolysis-related prognostic model of READ. Conclusions We found that a glycolysis-related prognostic model of COAD was not appropriate for READ, and we established a novel glycolysis-related two-gene risk model to effectively predict the prognosis of rectal cancer patients.
Supplementary Information The online version contains supplementary material available at 10.1186/s40246-022-00377-0.
Collapse
Affiliation(s)
- Zhenzhen Liu
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Zhentao Liu
- Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, People's Republic of China
| | - Xin Zhou
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Yongqu Lu
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Yanhong Yao
- Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, People's Republic of China
| | - Wendong Wang
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Siyi Lu
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Bingyan Wang
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Fei Li
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China
| | - Wei Fu
- Department of General Surgery, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, People's Republic of China.
| |
Collapse
|
5
|
Planas R, Santos R, Tomas-Ojer P, Cruciani C, Lutterotti A, Faigle W, Schaeren-Wiemers N, Espejo C, Eixarch H, Pinilla C, Martin R, Sospedra M. GDP-l-fucose synthase is a CD4 + T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis. Sci Transl Med 2019; 10:10/462/eaat4301. [PMID: 30305453 DOI: 10.1126/scitranslmed.aat4301] [Citation(s) in RCA: 60] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2018] [Accepted: 09/12/2018] [Indexed: 12/12/2022]
Abstract
Multiple sclerosis is an immune-mediated autoimmune disease of the central nervous system that develops in genetically susceptible individuals and likely requires environmental triggers. The autoantigens and molecular mimics triggering the autoimmune response in multiple sclerosis remain incompletely understood. By using a brain-infiltrating CD4+ T cell clone that is clonally expanded in multiple sclerosis brain lesions and a systematic approach for the identification of its target antigens, positional scanning peptide libraries in combination with biometrical analysis, we have identified guanosine diphosphate (GDP)-l-fucose synthase as an autoantigen that is recognized by cerebrospinal fluid-infiltrating CD4+ T cells from HLA-DRB3*-positive patients. Significant associations were found between reactivity to GDP-l-fucose synthase peptides and DRB3*02:02 expression, along with reactivity against an immunodominant myelin basic protein peptide. These results, coupled with the cross-recognition of homologous peptides from gut microbiota, suggest a possible role of this antigen as an inducer or driver of pathogenic autoimmune responses in multiple sclerosis.
Collapse
Affiliation(s)
- Raquel Planas
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Radleigh Santos
- Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway Port St. Lucie, FL 34987, USA
| | - Paula Tomas-Ojer
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Carolina Cruciani
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Andreas Lutterotti
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Wolfgang Faigle
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Nicole Schaeren-Wiemers
- Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland
| | - Carmen Espejo
- Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
| | - Herena Eixarch
- Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
| | - Clemencia Pinilla
- Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway Port St. Lucie, FL 34987, USA
| | - Roland Martin
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
| | - Mireia Sospedra
- Neuroimmunology and MS Research (nims), Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland.
| |
Collapse
|
6
|
Yang J, Kong P, Yang J, Jia Z, Hu X, Wang Z, Cui H, Bi Y, Qian Y, Li H, Wang F, Yang B, Yan T, Ma Y, Zhang L, Cheng C, Song B, Li Y, Xu E, Liu H, Gao W, Wang J, Liu Y, Zhai Y, Chang L, Wang Y, Zhang Y, Shi R, Liu J, Wang Q, Cheng X, Cui Y. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC. Technol Cancer Res Treat 2018; 17:1533033818781405. [PMID: 29950151 PMCID: PMC6048620 DOI: 10.1177/1533033818781405] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Esophageal squamous cell carcinoma is the sixth most lethal cancer worldwide and the
fourth most lethal cancer in China. Tissue-specific transplantation antigen P35B codifies
the enzyme GDP-d-mannose-4,6-dehydratase, which participates in the biosynthesis
of GDP-l-fucose. GDP-l-fucose is an important substrate involved in the
biosynthesis of many glycoproteins. Cancer cells are often accompanied by the changes in
glycoprotein structure, which affects the adhesion, invasion, and metastasis of cells. It
is not clear whether tissue-specific transplantation antigen P35B has any effect on the
development of esophageal squamous cell carcinoma. We used an immunohistochemical method
to assess the expression of tissue-specific transplantation antigen P35B in 104 esophageal
squamous cell carcinoma samples. The results showed tissue-specific transplantation
antigen P35B expression was associated with some clinical features in patients, such as
age (P = .017), clinical stage (P = .010), and lymph
node metastasis (P = .043). Kaplan-Meier analysis and log-rank test
showed that patients with esophageal squamous cell carcinoma having high tissue-specific
transplantation antigen P35B expression had a worse prognosis compared to the patients
with low expression (P = .048). Multivariate Cox proportional hazards
regression model showed that high expression of tissue-specific transplantation antigen
P35B could predict poor prognosis for patients with esophageal squamous cell carcinoma
independently. In conclusion, abnormal fucosylation might participate in the progress of
esophageal squamous cell carcinoma and tissue-specific transplantation antigen P35B may
serve as a novel biomarker for prognosis of patients with esophageal squamous cell
carcinoma.
Collapse
Affiliation(s)
- Jie Yang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,3 Department of Gastroenterology, The Second Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Pengzhou Kong
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Jian Yang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Zhiwu Jia
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Xiaoling Hu
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,4 Department of Pharmacology, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Zianyi Wang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,5 Taiyuan Lingde Secondary School, Taiyuan, Shanxi, PR China
| | - Heyang Cui
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yanghui Bi
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yu Qian
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Hongyi Li
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Fang Wang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Bin Yang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,6 Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China
| | - Ting Yan
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yanchun Ma
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Ling Zhang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Caixia Cheng
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,7 Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Bin Song
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,8 Department of Oncology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yaoping Li
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,9 Department of Anorectum, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China
| | - Enwei Xu
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,10 Department of Pathology, Shanxi Cancer Hospital, Taiyuan, Shanxi, PR China
| | - Haiyan Liu
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Wei Gao
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,11 Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Taiyuan, Shanxi, PR China.,12 Department of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Juan Wang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yiqian Liu
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yuanfang Zhai
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,13 Department of Anatomy, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Lu Chang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yi Wang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yingchun Zhang
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,13 Department of Anatomy, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Ruyi Shi
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Jing Liu
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,14 Department of General Surgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Qi Wang
- 3 Department of Gastroenterology, The Second Hospital, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Xiaolong Cheng
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China.,13 Department of Anatomy, Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - Yongping Cui
- 1 Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, PR China.,2 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, PR China
| |
Collapse
|